Foghorn Therapeutics (FHTX) Other Operating Expenses (2024 - 2025)

Foghorn Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Other Operating Expenses changed N/A year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (up 78.57% YoY), while the FY2025 annual figure was $4.3 million, up 78.57% from the prior year.
• Other Operating Expenses for Q4 2025 stood at $4.3 million, up from $2.4 million in the prior quarter.
• The five-year high for Other Operating Expenses was $4.3 million in Q4 2025, with the low at $2.4 million in Q2 2024.